INDOLE DERIVATIVE

An indole derivative represented by general formula (1), a pharmacologically acceptable salt thereof, and an immunosuppressant containing the same as an active ingredient, wherein R1? represents CV1? to C5? alkyl, C4? to C7? cycloalkylalkyl, C5? to C7? cycloalkenylalkyl, C7? to C14? aralkyl, C4? or...

Full description

Saved in:
Bibliographic Details
Main Authors ONODA, YOSHIHIRO, ENDO, TAKASHI, MIZUSUNA, AKIRA, KAWAI, KOJI, NAGASE, HIROSHI, MATSUMOTO, SHU
Format Patent
LanguageEnglish
Japanese
Published 12.12.1991
Subjects
Online AccessGet full text

Cover

Loading…
Abstract An indole derivative represented by general formula (1), a pharmacologically acceptable salt thereof, and an immunosuppressant containing the same as an active ingredient, wherein R1? represents CV1? to C5? alkyl, C4? to C7? cycloalkylalkyl, C5? to C7? cycloalkenylalkyl, C7? to C14? aralkyl, C4? or C5? trans-alkenyl, alkyl, C1? to C5? furanyl-2-ylalkyl, C1? to C5? thienyl-2-ylalkyl, vinyloxycarbonyl, trichloroethoxycarbonyl, benzyloxycarbonyl, C1? to C5? alkanoyl, C7? to C14? aralkylcarbonyl, 2-furoyl, thiophene-2-carbonyl, C4? to C7? cycloalkylcarbonyl, C3? to C8? alkenylcarbonyl or anisoyl; R2? represents hydrogen, C1? to C3? alkyl, benzyl or C1? to C5? alkanoyl; R3? represents hydrogen, fluorine, chlorine, bromine, nitro or C1? to C5? alkyl; R4? represents hydrogen, C1? to C5? alkyl, benzyl or phenyl; R5? represents hydrogen, hydroxy or C1? to C5? alkanoyloxy; and the general formula includes all of the (+), (-) and () forms. L'invention se rapporte à un dérivé d'indole représenté par la formule générale (1), à un sel pharmacologiquement acceptable de ce dérivé, et à un immunosuppresseur contenant ce dérivé comme ingrédient actif. Dans la formule (1), R1 représente un alkyle C1 à C5, un cycloalkylalkyle C4 à C7, un cycloalcénylalkyle C5 à C7 un aralkyle C7 à C14, un trans-alcényle C4 ou C5, un alkyle, un furanyl-2-ylalkyle C1 à C5 un thiényl-2-ylalkyle C1 à C5, un vinyloxycarbonyle, un trichloroéthoxycarbonyle, un benzyloxycarbonyle, un alcanoyle C1 à C5 un aralkylecarbonyle C7 à C14, un 2-furoyle, un thiophène-2-carbonyle, un cycloalkylecarbonyle C4 à C7, un alcénylecarbonyle C3 à C8 ou un anisoyle; R2 représente l'hydrogène, un alkyle C1 à C3, un benzyle ou un alcanoyle C1 à C5; R3 représente l'hydrogène, un fluor, un chlore, un brome, un nitro ou un alkyle C1 à C5; R4 représente l'hydrogène, un alkyle C1 à C5, un benzyle ou un phényle; R5 représente l'hydrogène, un hydroxy ou un alcanoyloxy C1 à C5; la formule générale (1) contenant la totalité des formes (+), (-) et (U).
AbstractList An indole derivative represented by general formula (1), a pharmacologically acceptable salt thereof, and an immunosuppressant containing the same as an active ingredient, wherein R1? represents CV1? to C5? alkyl, C4? to C7? cycloalkylalkyl, C5? to C7? cycloalkenylalkyl, C7? to C14? aralkyl, C4? or C5? trans-alkenyl, alkyl, C1? to C5? furanyl-2-ylalkyl, C1? to C5? thienyl-2-ylalkyl, vinyloxycarbonyl, trichloroethoxycarbonyl, benzyloxycarbonyl, C1? to C5? alkanoyl, C7? to C14? aralkylcarbonyl, 2-furoyl, thiophene-2-carbonyl, C4? to C7? cycloalkylcarbonyl, C3? to C8? alkenylcarbonyl or anisoyl; R2? represents hydrogen, C1? to C3? alkyl, benzyl or C1? to C5? alkanoyl; R3? represents hydrogen, fluorine, chlorine, bromine, nitro or C1? to C5? alkyl; R4? represents hydrogen, C1? to C5? alkyl, benzyl or phenyl; R5? represents hydrogen, hydroxy or C1? to C5? alkanoyloxy; and the general formula includes all of the (+), (-) and () forms. L'invention se rapporte à un dérivé d'indole représenté par la formule générale (1), à un sel pharmacologiquement acceptable de ce dérivé, et à un immunosuppresseur contenant ce dérivé comme ingrédient actif. Dans la formule (1), R1 représente un alkyle C1 à C5, un cycloalkylalkyle C4 à C7, un cycloalcénylalkyle C5 à C7 un aralkyle C7 à C14, un trans-alcényle C4 ou C5, un alkyle, un furanyl-2-ylalkyle C1 à C5 un thiényl-2-ylalkyle C1 à C5, un vinyloxycarbonyle, un trichloroéthoxycarbonyle, un benzyloxycarbonyle, un alcanoyle C1 à C5 un aralkylecarbonyle C7 à C14, un 2-furoyle, un thiophène-2-carbonyle, un cycloalkylecarbonyle C4 à C7, un alcénylecarbonyle C3 à C8 ou un anisoyle; R2 représente l'hydrogène, un alkyle C1 à C3, un benzyle ou un alcanoyle C1 à C5; R3 représente l'hydrogène, un fluor, un chlore, un brome, un nitro ou un alkyle C1 à C5; R4 représente l'hydrogène, un alkyle C1 à C5, un benzyle ou un phényle; R5 représente l'hydrogène, un hydroxy ou un alcanoyloxy C1 à C5; la formule générale (1) contenant la totalité des formes (+), (-) et (U).
Author ENDO, TAKASHI
NAGASE, HIROSHI
MIZUSUNA, AKIRA
KAWAI, KOJI
MATSUMOTO, SHU
ONODA, YOSHIHIRO
Author_xml – fullname: ONODA, YOSHIHIRO
– fullname: ENDO, TAKASHI
– fullname: MIZUSUNA, AKIRA
– fullname: KAWAI, KOJI
– fullname: NAGASE, HIROSHI
– fullname: MATSUMOTO, SHU
BookMark eNrjYmDJy89L5WQQ9PRz8fdxVXBxDfIMcwzxDHPlYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXx4f6WhoYWlgaGjobGRCgBAKolH0g
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID WO9118901A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO9118901A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:03:35 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Japanese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO9118901A13
Notes Application Number: WO1991JP00759
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19911212&DB=EPODOC&CC=WO&NR=9118901A1
ParticipantIDs epo_espacenet_WO9118901A1
PublicationCentury 1900
PublicationDate 19911212
PublicationDateYYYYMMDD 1991-12-12
PublicationDate_xml – month: 12
  year: 1991
  text: 19911212
  day: 12
PublicationDecade 1990
PublicationYear 1991
RelatedCompanies TORAY INDUSTRIES, INC
RelatedCompanies_xml – name: TORAY INDUSTRIES, INC
Score 2.5062442
Snippet An indole derivative represented by general formula (1), a pharmacologically acceptable salt thereof, and an immunosuppressant containing the same as an active...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title INDOLE DERIVATIVE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19911212&DB=EPODOC&locale=&CC=WO&NR=9118901A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSbZIM7NMBSZeA5O0RF2TZDMTXQujVFPdNItkw2SLZIMUM_B4h6-fmUeoiVeEaQQTQyZsLwz4nNBy8OGIwByVDMzvJeDyugAxiOUCXltZrJ-UCRTKt3cLsXVRS4FuFwO2HgyN1FycbF0D_F38ndWcnYH9NjW_IFugjAWw6nMEdpRYga1oc1BmcA1zAm1KKUCuUdwEGdgCgIbllQgxMGUlCjNwOsMuXhNm4PCFzncDmdCsVyzCIOjp5-Lv46rgAux5hTmGeIa5ijIouLmGOHvoAs2Oh_sjPtwf7gpjMQYWYPc-VYJBwdzQKDnJ3NQwNdncxCTFNM3SxMg81cI4EVSZmwIpSQZJnMZI4ZGTZuACL2syBF1eIsPAUlJUmioLrEBLkuTAXgcAfbRxkw
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSbZIM7NMBSZeA5O0RF2TZDMTXQujVFPdNItkw2SLZIMUM_B4h6-fmUeoiVeEaQQTQyZsLwz4nNBy8OGIwByVDMzvJeDyugAxiOUCXltZrJ-UCRTKt3cLsXVRS4FuFwO2HgyN1FycbF0D_F38ndWcnYH9NjW_IFugjAWw6nMEdpRYgS1sc1BmcA1zAm1KKUCuUdwEGdgCgIbllQgxMGUlCjNwOsMuXhNm4PCFzncDmdCsVyzCIOjp5-Lv46rgAux5hTmGeIa5ijIouLmGOHvoAs2Oh_sjPtwf7gpjMQYWYPc-VYJBwdzQKDnJ3NQwNdncxCTFNM3SxMg81cI4EVSZmwIpSQZJnMZI4ZGTZ-D0CPH1iffx9POWZuACL3EyBF1kIsPAUlJUmioLrExLkuTAwQAA-sx0hg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INDOLE+DERIVATIVE&rft.inventor=ONODA%2C+YOSHIHIRO&rft.inventor=ENDO%2C+TAKASHI&rft.inventor=MIZUSUNA%2C+AKIRA&rft.inventor=KAWAI%2C+KOJI&rft.inventor=NAGASE%2C+HIROSHI&rft.inventor=MATSUMOTO%2C+SHU&rft.date=1991-12-12&rft.externalDBID=A1&rft.externalDocID=WO9118901A1